🇺🇸 FDA
Pipeline program

A trial to learn how much [11C]savolitinib enters the brains of healthy participants

D5084C00016

Phase 1 other active

Quick answer

A trial to learn how much [11C]savolitinib enters the brains of healthy participants for Healthy Volunteers is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca AB
Indication
Healthy Volunteers
Phase
Phase 1
Modality
other
Status
active

Clinical trials